Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00284453 · ClinicalTrials.gov registry record
Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 65
- Enrollment target
NCT00284453: Completed study, sponsored by University of Pittsburgh.
NCT00284453 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00284453 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.
Primary Outcome
Identification of factors which are associated with periods of high ventricular arrhythmia burden (Day 1) by looking at gene expression from peripheral blood, in addition to levels of known markers of congestive heart failure (catecholamine levels, B-type natriuretic peptide, and troponin)in comparison to subject's return to own normal state (3 month +/- 30 days)
Interventions
- PROCEDURE Peripheral blood sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-08-26 |
| Est. Completion | 2018-12 |
What the finished NCT00284453 record still lists
NCT00284453 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Peripheral blood sampling is the first listed.
NCT00284453 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00284453 about?
NCT00284453 is a clinical study titled "Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm". The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.
What is the current status of trial NCT00284453?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2008-08-26. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00284453?
The interventions under investigation include: Peripheral blood sampling (PROCEDURE).
Who is sponsoring clinical trial NCT00284453?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI